Market Research Reports, Inc. has announced the addition of “Competitor Analysis: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists” research report to their offering. See more at- http://mrr.cm/Z7R

1. www.MarketResearchReports.com
Category : Biotechnology
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: August 14, 2014
 Number of Pages: 71
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 469
Price For Site User License: USD 938
Price For Global User License: USD 1,406
Delivery Time: Within 24 Hours (During Working Days)

3. www.MarketResearchReports.com
About the Report
The report provides a compilation of current active
projects in research and development of novel GLP-1
analogs and GLP-1 receptor agonists as well as co-
agonists.
The Competitor Analysis Series delivers NO-FRILLS, but
concise information about the pipeline of R&D projects
for targets, diseases, technologies and companies at low
prices. The information is provided in a tabular format
and fully referenced.

4. www.MarketResearchReports.com
Key Findings
The Competitive Intelligence Report Glucagon-Like
Peptide-1 (GLP-1) Receptor Agonists as of August 2014
provides a competitor analysis in the development
pipeline of novel GLP-1 analogs and GLP-1 receptor
agonists and co-agonists for treatment of diabetes and
obesity.
In the year 2013, the marketed daily and weekly GLP-1
agonists achieved combined sales of US$ 3,231 mln
representing 6.3% of the total diabetes care market.
The leading GLP-1 analog Victoza held 69% of the GLP-1
market and is further expanding its predominance in the
first half of 2014 with a 72% share of the GLP-1 market
which grew to 6.9% of the total diabetes care market.

5. www.MarketResearchReports.com
Key Findings Continues…
The increasingly attractive GLP-1 market provides an
opportunity of application of new technologies to prolong
the half-life of GLP-1 analogs as well as finding co-agonists
of GLP-1 receptor with additional receptors, such as
insulin, glucagon, GIP, gastrin or GLP-1.
In addition, expansion of indications for GLP-1 analogs
will contribute to further expand the GLP-1 market.

6. www.MarketResearchReports.com
Report Coverage
1. Selective GLP-1 Analogs for Metabolic Diseases
2. Selective GLP-1 Analogs for Non-Metabolic Diseases
3. Dual Target GLP-1 Analogs
4. Corporate GLP-1 Receptor Agonist R&D Pipelines
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

7. www.MarketResearchReports.com
Company Coverage (Partial List)
1. Addex Therapeutics
2. Aegis Therapeutics
3. Alteogen
4. Amunix
5. Arisaph Pharmaceuticals
6. Arisgen
7. AstraZeneca (MedImmune)
8. Boehringer Ingelheim
9. Camurus
10. ConjuChem
11. Dong-A Pharmaceutical (Dong-A Socio Holding)
12. Eli Lilly
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

8. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center

9. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/Z7R
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)